Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine/Benazepril vs Amlodipine in Severe Hypertension
NCT00136851Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of benazepril in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Percentage of subjects achieving blood pressure goal at 4 weeks. Started Dec 2004; status: completed.
02
Drugs
benazepril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00136851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136851.